Case Report

Accepted on 06 Nov 2024

Case Report: Successful Use of Ruxolitinib to Treat Interstitial Pneumonia as an Unusual Primary Presentation in Primary Myelofibrosis-Two Birds with One Stone

in Hematologic Malignancies

Ping Ping Xiao
Zhigao Dong
Qing Qing Wang
Jun Nan Su
Yong Quan Chen
Yi Wan Lin

Frontiers in Oncology

doi 10.3389/fonc.2024.1475036

Case Report

Accepted on 06 Nov 2024

Case report: Identification of a novel TOR1AIP2::ETV6 transcript with FLT3-ITD mutation in acute myeloid leukemia progressed from myelodysplastic symdrome

in Hematologic Malignancies

Jun Xia
Guanqun Yang
Qingling Yu
Ruiyi Zhang
Man Wang
Hongli Sun
Heng Chen
Lingling Wang
Ping Chen
Kai-Li Gu

Frontiers in Oncology

doi 10.3389/fonc.2024.1466590

Clinical Trial

Accepted on 05 Nov 2024

A sixteen-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot study

in Hematologic Malignancies

Frankie Fantom Brown
Rebecca Oliver
Rachel Eddy
Adam J Causer
Annabelle Emery
Harrison D Collier-Bain
David Dutton
Josephine Crowe
Daniel Augustine
John Graby

Frontiers in Oncology

doi 10.3389/fonc.2024.1472551

Original Research

Accepted on 05 Nov 2024

The Characteristics of Patients with Multiple Myeloma Surviving Over 10 Years

in Hematologic Malignancies

Beihui Huang
Hongning Zhang
Junru Liu
Jingli Gu
Meilan Chen
Lifen Kuang
Xiaozhe Li
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1490630

Mini Review

Published on 04 Nov 2024

Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma

in Hematologic Malignancies

Oliver Tomkins

Frontiers in Oncology

doi 10.3389/fonc.2024.1490202

272 views

Original Research

Published on 31 Oct 2024

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy

in Hematologic Malignancies

Charles Dumontet
Herve GHESQUIERES
Emmanuel BACHY
Emmanuel Massy
Pierre SESQUES

Frontiers in Oncology

doi 10.3389/fonc.2024.1436587

278 views

Case Report

Published on 31 Oct 2024

TIPIC syndrome in a patient following sorafenib treatment for acute myeloid leukemia: a rare case report

in Hematologic Malignancies

Jinman Zhong
Chang Chen

Frontiers in Oncology

doi 10.3389/fonc.2024.1484256

261 views

Review

Published on 31 Oct 2024

Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era

in Hematologic Malignancies

Argiris Symeonidis
Anne-Lise De Lastic
Vasileios Lazaris
Theodora Chatzilygeroudi
Evgenia Verigou

Frontiers in Oncology

doi 10.3389/fonc.2024.1447001

228 views

Original Research

Published on 31 Oct 2024

The identification and correction of pseudohypercalcemia

in Hematologic Malignancies

Juan Li
Junru Liu
Tongyong Yu

Frontiers in Oncology

doi 10.3389/fonc.2024.1441851

267 views

Brief Research Report

Published on 24 Oct 2024

Complex karyotypes in hematologic disorders: a 12-year single-center study from Lebanon

in Hematologic Malignancies

Alain CHEBLY
Zeinab El Mounajjed

Frontiers in Oncology

doi 10.3389/fonc.2024.1480793

245 views

Case Report

Accepted on 22 Oct 2024

Paraganglioma Masquerading as Angiosarcoma: Diagnostic Dilemma in Vascular Tumors

in Hematologic Malignancies

Lenny Suryani Safri
Ahilan Raj Rajoo
Saravanan Kannairan
Hisham Arshad Habeebullah Khan
Mohamad Azim Md Idris
Geok Chin Tan
Kishen Raj Chandra Sakaran

Frontiers in Oncology

doi 10.3389/fonc.2024.1462956

Mini Review

Published on 22 Oct 2024

The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma

in Hematologic Malignancies

Amanda Cashen

Frontiers in Oncology

doi 10.3389/fonc.2024.1392653

267 views

Review

Published on 22 Oct 2024

Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma

in Hematologic Malignancies

Joseph Tuscano
Gabriel Marquez-Arreguin
Naseem Esteghamat

Frontiers in Oncology

doi 10.3389/fonc.2024.1481950

417 views

Case Report

Accepted on 21 Oct 2024

Hemangiopericytoma following allogeneic hematopoietic stem cell transplantation in a patient with primary plasma cell leukemia: the first case report

in Hematologic Malignancies

Yajun Shi
Guohao Liang
Haiying Zhang
Yaqing Wang
Ying Han
Shenglian Tong
Shunyu Liang
Ying Wang
Hai Bai
Rui Xi

Frontiers in Oncology

doi 10.3389/fonc.2024.1467237

Review

Accepted on 21 Oct 2024

Recommendations for the Effective Use of T-Cell-Redirecting Therapies: A Canadian Consensus Statement

in Hematologic Malignancies

Guido Lancman
Kevin Song
Darrell White
Tina Crosbie
Ismail Sharif
Marianne Emond
Muhammad Saleem Raza
Martine Elias
Rayan Kaedbey
Michael P Chu

Frontiers in Oncology

doi 10.3389/fonc.2024.1446995

Original Research

Accepted on 21 Oct 2024

Bone marrow involvement in solid tumors -a retrospective observational study

in Hematologic Malignancies

Bicheng Zhang
Lan Jin
Dang Wu
Jing Xu
Siyu Guo
Jingjing Li
Ting Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1434709

Navigation group

Articles

Case Report: Successful Use of Ruxolitinib to Treat Interstitial Pneumonia as an Unusual Primary Presentation in Primary Myelofibrosis-Two Birds with One Stone

Case report: Identification of a novel TOR1AIP2::ETV6 transcript with FLT3-ITD mutation in acute myeloid leukemia progressed from myelodysplastic symdrome

A sixteen-week progressive exercise training intervention in treatment-naïve chronic lymphocytic leukaemia: a randomised-controlled pilot study

The Characteristics of Patients with Multiple Myeloma Surviving Over 10 Years

Review of BCL2 inhibitors for the treatment of Waldenström’s macroglobulinaemia and non-IgM lymphoplasmacytic lymphoma

End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapy

TIPIC syndrome in a patient following sorafenib treatment for acute myeloid leukemia: a rare case report

Immunophenotyping myelodysplastic neoplasms: the role of flow cytometry in the molecular classification era

The identification and correction of pseudohypercalcemia

Complex karyotypes in hematologic disorders: a 12-year single-center study from Lebanon

Paraganglioma Masquerading as Angiosarcoma: Diagnostic Dilemma in Vascular Tumors

The evolving role of checkpoint inhibitors in the treatment of Hodgkin lymphoma

Cellular therapy in older adults with relapsed/refractory diffuse large B-cell lymphoma

Hemangiopericytoma following allogeneic hematopoietic stem cell transplantation in a patient with primary plasma cell leukemia: the first case report

Recommendations for the Effective Use of T-Cell-Redirecting Therapies: A Canadian Consensus Statement

Bone marrow involvement in solid tumors -a retrospective observational study